Table 1.

Characteristics of patients.

Patient number and reference	Sex	Age, year	Duration of gout, year	Severity of gout	history Family	Site of amyloid deposition	Treatment
111	Male	42	25	Chronic tophaceous gout		Generalised	Azathioprine, dialysis
211	Male	23	9	Chronic tophaceous gout	+	Kidneys	Probenecid, dialysis
311	Male	32	4	Monoarthritis		Kidneys	Sulphinpyrazone
412	Male	72	37	Chronic tophaceous gout		Kidneys	High doses of salicylates, allopurinol, dialysis
513	Male	46	32	Chronic tophaceous gout	+	Kidneys, adrenals, testicular blood vessels	Only colchicine during an attack
613	Male	39	3	Oligoarthritis		Kidneys	Analgesics and probenecid
714	Male	85	10	Chronic tophaceous gout		Rectum, kidneys probable	Colchicine started after diagnosis of amyloidosis
815	Male	49	20	Chronic tophaceous gout		Kidneys, liver, subcutaneous fat	No use of colchicine at all
916	Male	61		Chronic tophaceous gout		Kidneys
1017	Male	46	20	Chronic tophaceous gout		Rectum, kidneys probable	No use of colchicine at all
1118	Male	56	15	Chronic tophaceous gout	+	Kidneys
1218	Male	44	10	Chronic tophaceous gout	+	Rectum, kidneys	Allopurinol after diagnosis of amyloidosis Allopurinol, colchicine started
1319	Male	57	20	Chronic tophaceous gout		Kidneys	Only colchicine during an attack
1420	Female	47	1	Oligoarthritis		Kidney, liver	Allopurinol, colchicine and prednisolone | anakinra and tocilizumab, infliximab | dialysis and medical nephrectomy
15	Male	62	36	Chronic tophaceous gout		Kidneys, gastrointestinal tract; adrenal glands	Canakinumab, prednisone, colchicine, allopurinol, sotalol